FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreStrength in Numbers Make these Memberships a Force Multiplier

ACR® CEO Dana H. Smetherman, MD, MPH, MBA, FACR, called on American College of Radiation Oncology (ACRO) annual meeting attendees to join both ACRO and ACR. She and ACRO leadership stressed that both specialties are “stronger together,” and radiology and radiation oncology professionals can amplify their influence when they speak with one coordinated voice.
Dr. Smetherman and ACRO leaders emphasized that unity — not division — drives progress in patient care, fair reimbursement, and the future of both specialties. “Membership in both organizations can be a force multiplier,” Smetherman said.
She highlighted the ACR’s wide‑ranging quality, safety, education, and research programs that directly support radiation oncologists, including accreditation programs, in training exams and other educational offerings, and major clinical research initiatives.
Smetherman particularly showcased ACR’s strong advocacy reach, noting that in 2025, the College engaged in hundreds of congressional and regulatory meetings and submitted nearly 100 letters to decisionmakers on issues affecting radiation oncology and radiology.
She underscored ACR’s unmatched organizational capacity in government relations, economics, and policy development — powered by RADPAC® and more than 2,000 volunteers.
Smetherman pointed to ACR’s leadership in CPT® and RUC processes, private payer negotiations, and state‑level advocacy through its active chapters nationwide, emphasizing how collaborative work across organizations strengthens the entire field.
She also promoted the College’s pipeline-building efforts, including numerous robust fellowships for trainees. She also encouraged young professionals to engage early through volunteering and leadership roles, noting that the voice and involvement of ACR members (including diagnostic and interventional radiologists, radiation oncologists, medical physicists, nuclear medicine physicians, and allied health professionals) continue to shape improvements and broaden leadership across the entire Radiology community.
For more information, contact Trina Behbahani, ACR Vice President of Member Services and Governance.
FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreLower Fee Now in Effect to File No Surprises Act Disputes
Federal agencies released a final rule that updates the No Surprises Act independent dispute resolution process. The rule lowers the IDR administrative or filing fee from $115 to $15.
Read moreACR Urges Funding for NIH All of Us Program
ACR urges Congress to provide dedicated funding for NIH’s All of Us Research Program, a leader in precision medicine technologies and a valuable tool for researchers.
Read more